HB
INSIDER · ELVN · Enliven Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
Hohl Benjamin
Every open-market transaction filed under this name, Sep 17 to Oct 19.
Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$535K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 19 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 6,018 | $38.48 | $232K | — |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 289 | $51.49 | $15K | — |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 2,194 | $50.72 | $111K | — |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sell | 3,535 | $50.03 | $177K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.